GlassScriptPhysician profile
Danish Ejaz Bhatti
NPI 1982858239
$55,466.99
in general payments reported to CMS, 2019-2025
13 companies · $28.79 in 2025
The $28.79 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $31K · 2020: $12K · 2021: $9,728 · 2022: $2,372 · 2023: $172 · 2024: $335 · 2025: $28.79.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $536.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $535.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Adamas Pharmaceuticals, INC. | $19,516.78 | 2019-2020 | |
| Acadia Pharmaceuticals INC | $19,010.36 | 2019-2022 | |
| Abbvie INC. | $9,123.29 | 2021-2024 | Duopa |
| Acorda Therapeutics, INC | $2,825.00 | 2020 | |
| Amneal Pharmaceuticals LLC | $2,250.00 | 2020 | |
| Boston Scientific Corporation | $1,135.06 | 2019 | |
| Medtronic, INC. | $780.00 | 2021 | |
| Medtronic USA, INC. | $260.00 | 2020 | |
| Abbott Laboratories | $214.95 | 2019-2024 | Infinity |
| Microtransponder, INC. | $185.34 | 2024 | |
| Eisai INC. | $121.96 | 2023 | |
| Averitas Pharma INC. | $28.79 | 2025 | Qutenza |
| Teva Pharmaceuticals USA, INC. | $15.46 | 2023 | Austedo Xr |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danish Bhatti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.